Evidence map›Paper›PMID 31424551›Full record

ArticleMolecular biology and evolution2019

NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods.

Aideen C Roddy, Anna Jurek-Loughrey, Jose Souza, Alan Gilmore, Paul G O'Reilly, Alexey Stupnikov, David Gonzalez de Castro, Kevin M Prise, Manuel Salto-Tellez, Darragh G McArt

Open access · hybridAbstract readValidation Study
In one paragraph

Article in Molecular biology and evolution, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Aideen C RoddyCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Anna Jurek-LoughreySchool of Electronics, Electrical Engineering and Computer Science, Queen's University Belfast, Belfast, United Kingdom.
Jose SouzaCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Alan GilmoreCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Paul G O'ReillyCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Alexey StupnikovCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
David Gonzalez de CastroCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Kevin M PriseCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Manuel Salto-TellezCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Darragh G McArtCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
Queen's University Belfast · GBJohns Hopkins University · US

Funding

Cancer Research UK 20256Cancer Research UK C11512/A20877
6 · The paper itself

Abstract

Longitudinal next-generation sequencing of cancer patient samples has enhanced our understanding of the evolution and progression of various cancers. As a result, and due to our increasing knowledge of heterogeneity, such sampling is becoming increasingly common in research and clinical trial sample collections. Traditionally, the evolutionary analysis of these cohorts involves the use of an aligner followed by subsequent stringent downstream analyses. However, this can lead to large levels of information loss due to the vast mutational landscape that characterizes tumor samples. Here, we propose an alignment-free approach for sequence comparison-a well-established approach in a range of biological applications including typical phylogenetic classification. Such methods could be used to compare information collated in raw sequence files to allow an unsupervised assessment of the evolutionary trajectory of patient genomic profiles. In order to highlight this utility in cancer research we have applied our alignment-free approach using a previously established metric, Jensen-Shannon divergence, and a metric novel to this area, Hellinger distance, to two longitudinal cancer patient cohorts in glioma and clear cell renal cell carcinoma using our software, NUQA. We hypothesize that this approach has the potential to reveal novel information about the heterogeneity and evolutionary trajectory of spatiotemporal tumor samples, potentially revealing early events in tumorigenesis and the origins of metastases and recurrences. Key words: alignment-free, Hellinger distance, exome-seq, evolution, phylogenetics, longitudinal.

Indexed as

Biological EvolutionGenetic HeterogeneityGenetic TechniquesSoftwareHumansNeoplasms

Identifiers

PMID31424551
PMCPMC6878956
OpenAlexW2969864229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.